Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Aripiprazole LAI in Schizophrenia
NCT03839251Phase 4Completed
- Sponsor
- Jeonbuk National University Hospital
- Start
- Jun 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Jeonbuk National University Hospital. Started Jun 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03839251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03839251.